Naratriptan Tablet
Product Images NDC 87063-288

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Naratriptan (NDC 87063-288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figa (Figa)

A line graph showing the estimated probability of response over time in minutes from initial dose for naratriptan tablets and placebo. Three lines represent placebo, naratriptan 1 mg, and naratriptan 2.5 mg. Probability increases over 240 minutes, with higher responses at 2.5 mg, followed by 1 mg, and lowest for placebo.*

FDA Label Image

Figb (Figb)

A line graph showing the estimated probability of remediation or rescue over 24 hours from the initial dose for naratriptan tablets in 1 mg and 2.5 mg strengths compared to placebo. The x-axis represents time in hours, and the y-axis represents probability percentage. Three lines depict placebo, naratriptan 1 mg, and naratriptan 2.5 mg groups with distinct markers for each.*

FDA Label Image

1 mg (Label 1 mg)

Multiple packaging labels for Naratriptan Tablets USP 1 mg from Enovachem Pharmaceuticals, showing various package quantities: 9, 12, 30, 60, and 90 tablets. Labels include NDC numbers, barcode, drug status as prescription only, and storage instructions. Manufactured for Avet Pharmaceuticals Inc, the tablets are described as yellow, round, biconvex, film-coated with debossed '153'.*

FDA Label Image

2.5 (Label 2 5 mg)

Labels for Naratriptan Tablets, USP 2.5 mg by Enovachem Pharmaceuticals, showing various package quantities including 9, 12, 30, 60, and 90 tablets. Each label states the NDC numbers, packaging or relabeling information, manufacturer details, and storage instructions. The tablets are described as white, biconvex film-coated with debossed imprint '154.' All labels include cautionary statements about prescription-only dispensing and storage conditions.*

FDA Label Image

Image (Stru Nara)

Chemical structure of the active ingredient naratriptan hydrochloride, showing its molecular arrangement with functional groups including a methylsulfonamide moiety and a piperidine ring containing a methyl substitution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.